User profiles for Aliaksandr Skrahin
 | Aliaksandr Skrahin / Скрягин Александр ЕгоровичДоцент, Кафера анестезиологии и реаниматологии, Белорусский государственный … Verified email at bsmu.by Cited by 814 |
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 …
Background Novel treatment options are urgently needed for multidrug-resistant (MDR) and
extensively drug-resistant (XDR) tuberculosis, which are associated with immune …
extensively drug-resistant (XDR) tuberculosis, which are associated with immune …
The TB portals: an open-access, web-based platform for global drug-resistant-tuberculosis data sharing and analysis
…, I Akhundova, S Ismayilova, A Skrahin… - Journal of clinical …, 2017 - Am Soc Microbiol
The TB Portals program is an international consortium of physicians, radiologists, and
microbiologists from countries with a heavy burden of drug-resistant tuberculosis working with …
microbiologists from countries with a heavy burden of drug-resistant tuberculosis working with …
[HTML][HTML] Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences
Background Despite that confirmative diagnosis of pulmonary drug-sensitive tuberculosis (DS-TB)
and multidrug resistant tuberculosis (MDR-TB) is determined by microbiological …
and multidrug resistant tuberculosis (MDR-TB) is determined by microbiological …
Whole-genome sequencing of Mycobacterium tuberculosis provides insight into the evolution and genetic composition of drug-resistant tuberculosis in Belarus
…, A Gabrielian, S Hoffner, A Skrahin… - Journal of clinical …, 2017 - Am Soc Microbiol
The emergence and spread of drug-resistant Mycobacterium tuberculosis (DR-TB) are
critical global health issues. Eastern Europe has some of the highest incidences of DR-TB, …
critical global health issues. Eastern Europe has some of the highest incidences of DR-TB, …
[HTML][HTML] Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring
Tuberculosis (TB) is currently the world’s leading cause of infectious mortality. The complex
immune response of the human body to Mycobacterium tuberculosis (M. tb) results in a wide …
immune response of the human body to Mycobacterium tuberculosis (M. tb) results in a wide …
[HTML][HTML] Major challenges in clinical management of TB/HIV coinfected patients in Eastern Europe compared with Western Europe and Latin America
Objectives Rates of TB/HIV coinfection and multi-drug resistant (MDR)-TB are increasing in
Eastern Europe (EE). We aimed to study clinical characteristics, factors associated with MDR-…
Eastern Europe (EE). We aimed to study clinical characteristics, factors associated with MDR-…
[HTML][HTML] Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis
A Skrahin, HE Jenkins, H Hurevich… - Journal of clinical …, 2016 - Elsevier
Introduction We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB).
Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its …
Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its …
[HTML][HTML] Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm …
…, D Viatushka, T Apanasevich, A Skrahin… - The Lancet …, 2024 - thelancet.com
Background Around 500 000 people worldwide develop rifampicin-resistant tuberculosis
each year. The proportion of successful treatment outcomes remains low and new treatments …
each year. The proportion of successful treatment outcomes remains low and new treatments …
Management of MDR-TB in HIV co-infected patients in Eastern Europe: results from the TB: HIV study
Objectives Mortality among HIV patients with tuberculosis (TB) remains high in Eastern Europe
(EE), but details of TB and HIV management remain scarce. Methods In this prospective …
(EE), but details of TB and HIV management remain scarce. Methods In this prospective …
Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology
…, B Assmus, F Knebel, S Gingele, A Skrahin… - Annals of …, 2021 - Taylor & Francis
Background Hereditary Transthyretin-Related Amyloidosis, a clinically heterogeneous
autosomal dominant disease caused by pathogenic variants in the TTR gene, is characterized by …
autosomal dominant disease caused by pathogenic variants in the TTR gene, is characterized by …